The Science & Treatment of Obsessive Compulsive Disorder (OCD) | Huberman Lab Essentials
In a Nutshell
OCD is driven by a dysfunctional cortico-striatal-thalamic loop that links intrusive obsessions to anxiety-relieving compulsions, creating a self-reinforcing cycle. Exposure-based CBT is the most effective treatment because it teaches patients to tolerate the anxiety without performing the compulsion, directly breaking that neural loop. SSRIs provide moderate relief but do not outperform CBT alone, while cannabis shows no benefit and TMS offers only modest, adjunctive effects.
These notes were generated by AI and may contain inaccuracies.
OCD includes obsessions (thoughts) and compulsions (actions) that are often linked, with the compulsion designed to relieve the obsession. Obsessions are intrusive thoughts that people do not want or enjoy, and compulsions provide only brief relief before reinforcing or strengthening the obsession.
OCD affects 2.5% to 4% of people. It ranks as the seventh most debilitating illness among all illnesses, including asthma and cancer. The disorder causes significant impairment in work performance, relational interactions, and daily functioning. People spend extensive time on obsessions and compulsions, displacing essential activities like commuting, homework, work, listening, social interaction, sports, and exercise.
OCD falls into three main categories:
- Checking obsessions and compulsions (e.g., checking the stove or locks)
- Repetition obsessions and compulsions (e.g., counting sequences like 1-2-3-4-5-6-7-6-5-4-3-2-1 repeatedly)
- Order obsessions and compulsions (including cleanliness, alignment, symmetry, completeness, and contamination concerns)
Order-related obsessions can manifest as a need for symmetry, exact positioning of objects, or feelings of incompleteness. Disgust and contamination fears are also common, such as avoiding handshakes or contaminated objects. Engaging in compulsions strengthens the obsession, creating a debilitating loop.
Anxiety binds obsessions and compulsions. Fear involves heightened autonomic arousal (increased heart rate, breathing, sweating) in response to an immediate threat. Anxiety involves similar responses without a clear and present danger.
Twin studies show that 40-50% of OCD cases have a genetic component. Genetic concordance varies between identical and fraternal twins, including those sharing or not sharing the same amniotic sac.
A cortico-striatal-thalamic loop is implicated in OCD. This circuit includes:
- The cortex (involved in perception and understanding)
- The striatum (involved in action selection and suppression)
- The thalamus (an egg-like central structure with channels that relay sensory information to the cortex while the thalamic reticular nucleus acts as a gate controlling what reaches conscious awareness)
Dysfunction in this corticostriatal thalamic loop is considered the primary basis for OCD symptoms.
Brain imaging studies using fMRI and PET scans show increased activity in the corticostriatal thalamic loop when individuals with contamination obsessions are exposed to triggers like a sweaty towel. Effective drug treatments such as SSRIs reduce both symptoms and activity in this circuit.
The Y-BOCS is the standard diagnostic tool for OCD. Clinicians first define obsessions as unwelcome, distressing, recurrent thoughts that may seem senseless or against one's will. Compulsions are defined as driven behaviors that may be recognized as excessive, with anxiety persisting until the behavior is completed.
The assessment includes checklists for aggressive obsessions, contamination obsessions, sexual obsessions, saving obsessions, moral obsessions, and symmetry concerns. It emphasizes identifying the precise, most catastrophic fear driving the obsession.
Exposure-based cognitive behavioral therapy (CBT) aims to help patients tolerate anxiety rather than relieve it. Patients progressively confront their precise source of anxiety while preventing the usual compulsion (ritual prevention). This interrupts the corticostriatal thalamic loop by teaching that anxiety can exist without the compulsion.
Treatment typically involves two planning sessions followed by 15 exposure sessions conducted twice weekly or more, spanning several to 12 weeks. This therapy must be administered by trained, licensed clinicians.
Research by Dr. Helen Blair Simpson at Columbia University compared treatments:
- Placebo showed no significant reduction in symptoms
- Cognitive behavioral therapy alone produced a dramatic reduction, with symptom severity scores dropping from 25 to approximately 11 within four weeks
- SSRIs produced a significant but smaller reduction in symptoms compared to CBT alone
- Combining CBT and SSRIs did not yield additional symptom reduction beyond CBT alone
CBT is identified as the most effective treatment. Ideal scenarios may combine CBT with medication under physician supervision, though decisions require close consultation with a licensed physician.
Despite the fact that selective serotonin reuptake inhibitors can be effective in reducing the symptoms of OCD at least somewhat and certainly more than placebo, there is very little if any evidence that the serotonin system is disrupted in OCD. This is a somewhat consistent theme in the field of psychiatry where a given drug can be very effective or even partially effective in reducing symptoms or in changing the overall landscape of a psychiatric disorder or illness and yet there is very little if any evidence that that particular system is what's causal for OCD or anxiety or depression.
Earlier discussion of learning anxiety tolerance rather than reducing anxiety to treat OCD does not rule out cannabis as a candidate for treatment. Dr. Blair Simpson conducted a study titled "Acute Effects of Cannabinoids on Symptoms of Obsessive-Compulsive Disorder: A Human Laboratory Study." The data suggests that smoked cannabis whether containing primarily THC or CBD has little acute impact on OCD symptoms and yields smaller reductions in anxiety compared to placebo. No positive effect in reducing symptoms of OCD was observed from cannabis or CBD.
Transcranial magnetic stimulation uses a magnetic coil placed on the skull to direct magnetic energy toward particular areas of the brain to either suppress or activate brain regions. Data shows that when TMS is applied to areas involved in the generation of motor action such as motor areas or supplementary motor areas while people think about or have intrusive thoughts, the TMS coil can interrupt the motor behaviors and compulsive behaviors. In a small cohort of studies and small number of patients this has been shown to be effective not just while the coil is on the head but after treatment in reducing OCD symptoms by disrupting the tendency for compulsive behavior to be automatic. TMS is not considered a magic bullet.
There is excitement about the combination of TMS with drug treatments or the combination of TMS with cognitive behavioral therapy. Dr. Blair Simpson's lab has explored the role of mindfulness meditation for the treatment of OCD. The data are complicated. The National Institutes of Health has launched a division of complimentary health devoted to exploration of breathing practices, meditation, and related approaches. This institute exists alongside the cancer institute, hearing and deafness institute, and vision institute.
Mindfulness meditation can be useful in the treatment of OCD mainly by impacting focus and ability to engage in cognitive behavioral therapies. It is very unlikely to have a direct effect on relieving symptoms. Rather meditation increases focus on cognitive behavioral therapy homework and reduces focus on other things thereby indirectly improving symptoms of OCD.
A fairly large number of studies have explored how nutraceuticals and over-the-counter supplements can impact treatment of obsessive-compulsive disorder. Inositol specifically myo-inositol at 900 milligrams can improve sleep and reduce anxiety when taken at that dosage or higher dosages. There is potential for more systematic exploration of lower dosages of nutraceuticals in the context of OCD treatment. These compounds need to be explored in combination with behavioral therapies and possibly with brain machine interface approaches like cranial magnetic stimulation.
The goal is to provide an opportunity to drill deep into the neural circuitry and understanding of where OCD comes from and to give a sense of how individual behavioral and drug treatments work and do not work so that informed choices can be made. OCD is an extremely common and extremely debilitating condition. The hope is that those who have OCD or know people who have it will gain sympathy and understanding and be able to direct treatment toward better options and apply those treatments for relief.
In closing thanks are extended for the in-depth discussion about the mechanisms and various treatments for obsessive-compulsive disorder and some of the related disorders along with appreciation for interest in science.
Keep Andrew Huberman in your library
Save the videos and channels worth coming back to, and find them again in one place.
